PD-L1 Antibody Comparison in Urothelial Carcinoma

Affiliations

¹ Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
² Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
³ Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
⁴ Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
⁵ Department of Pathology, Free University Medical Center, Amsterdam, The Netherlands.
⁶ Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands. Electronic address: r.dewit@erasmusmc.nl.
⁷ Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.

Comparative Study

Maud Rijnders et al. Eur Urol. 2019 Mar.

. 2019 Mar;75(3):538-540.

doi: 10.1016/j.eururo.2018.11.002. Epub 2018 Nov 27.

¹ Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
² Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
³ Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
⁴ Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
⁵ Department of Pathology, Free University Medical Center, Amsterdam, The Netherlands.
⁶ Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands. Electronic address: r.dewit@erasmusmc.nl.
⁷ Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.

No abstract available

Comment in

Re: Maud Rijnders, Astrid A.M. van der Veldt, Tahlita C.M. Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538-40.
Gevaert T, Eckstein M, Montironi R, Lopez-Beltran A. Gevaert T, et al. Eur Urol. 2019 Jun;75(6):e162-e163. doi: 10.1016/j.eururo.2019.01.038. Epub 2019 Feb 1. Eur Urol. 2019. PMID: 30712970 No abstract available.
Reply to Thomas Gevaert, Markus Eckstein, Rodolfo Montironi, and Antonio Lopez-Beltran's Letter to the Editor re: Maud Rijnders, Astrid A.M. van der Veldt, Tahlita C.M. Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538-40.
Rijnders M, van der Veldt AAM, de Wit R, van Leenders GJLH. Rijnders M, et al. Eur Urol. 2019 Jun;75(6):e160-e161. doi: 10.1016/j.eururo.2019.01.039. Epub 2019 Feb 2. Eur Urol. 2019. PMID: 30723047 No abstract available.